Multistep molecular trajectory of monocytic myeloid-derived suppressor cell induction by diffuse large B-cell lymphoma cells
- 22 January 2026
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 804, 153287
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science (25K11632)
- Japan Society for the Promotion of Science (22K08513)
- Japanese Society of Hematology
- Japan Agency for Medical Research and Development (24ck0106943h0001)
This publication has 55 references indexed in Scilit:
- Cancer-associated fibroblasts induce monocytic myeloid-derived suppressor cell generation via IL-6/exosomal miR-21-activated STAT3 signaling to promote cisplatin resistance in esophageal squamous cell carcinomaCancer Letters, 2021
- Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design studyThe Lancet, 2020
- Evolving complexity of MIF signalingCellular Signalling, 2019
- Deciphering myeloid-derived suppressor cells: isolation and markers in humans, mice and non-human primatesCancer Immunology, Immunotherapy, 2019
- Macrophage migration inhibitory factor (MIF) is induced by cytotoxic drugs and is involved in immune escape and migration in childhood rhabdomyosarcomaCancer Immunology, Immunotherapy, 2016
- Cancer Stem Cell-Secreted Macrophage Migration Inhibitory Factor Stimulates Myeloid Derived Suppressor Cell Function and Facilitates Glioblastoma Immune EvasionStem Cells, 2016
- Bcl-2 is a better therapeutic target than c-Myc, but attacking both could be a more effective treatment strategy for B-cell lymphoma with concurrent Bcl-2 and c-Myc overexpressionExperimental Hematology, 2011
- Serum macrophage migration‐inhibitory factor as a diagnostic and prognostic biomarker for gastric cancerCancer, 2009
- Overexpression of macrophage migration inhibitory factor induces angiogenesis and deteriorates prognosis after radical resection for hepatocellular carcinomaCancer, 2005
- Characterization and comparison of two newly established epstein-barr virus-negative lymphoma B-cell lines: Surface markers, growth characteristics, cytogenetics, and transplantabilityCancer, 1988